1. Current and future use of drug combinations

2. Fixed drug combinations hypertension:
a). Diuretics: Thiazides and potassium sparing agents
b). Beta-blockers and diuretics
c). ACEI + diuretics
d). ARB's + diuretics
e). ACEI + CCB (Dihydropiridine group)
f). ACEI + CCB Non Dihydropiridine group
g). CCB + Beta-blocking agents
h). ARB's + CCB
i). ARB's + ACE
j). Renin inhibitors and diuretics
k). Renin inhibitors and ACEI
l). Renin inhibitors and ARBs
m). Renin inhibitors and CCB

3. Fixed drug combinations hyperlipidemia:
a) statins/cholesterol absorption inhibitors
b) statins/niacin
c) fibrate/metformin

4. Fixed drug combinations diabetes:
a). Rosiglitazone/metformin combination
b). Pioglitazone/metformin combination
c). Metformin/ glibenclamide combination
d). Metformin HCI/ Glipizide

5. Polypill - Different compounds
 a) statin/ CCB
b) statin/aspirin
c) statin/ACE
d) fibrate/metformin

6. Current and future clinical studies in fixed dose combination therapy

7. Patient populations likely to benefit from fixed dose combination therapy

8. Compliance and fixed dose combination therapy

9. Cost and fixed dose combination therapy